Navigation Links
3SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results
Date:8/15/2011

t revenues. Net revenues increased by 29.0% to RMB136.1 million (US$21.1 million) for the second quarter of 2011 from RMB105.5 million (US$15.6 million) for the same period in 2010. This increase was largely due to continued strong sales of EPIAO and TPIAO which grew by 27.7% and 31.7%, respectively, over the same period in 2010. TPIAO remained 3SBio's second largest revenue contributor in the quarter, accounting for an all-time high of 31.1% of total net revenues. Export sales increased by 54.1% year-on-year to RMB4.5 million (US$0.7 million), and revenues from Iron Sucrose rose 39.1% year-on-year to RMB6.2 million (US$1.0 million).

Gross profit. As a result of continued sales growth from key products, gross profit for the second quarter of 2011 increased by 27.7% to RMB121.5 million (US$18.8 million) from RMB95.2 million (US$14.0 million) for the same period in 2010. Gross margins declined 1.0% to 89.2% for the second quarter of 2011 from 90.2% for the same period in 2010. The decline was mainly attributable to new plant depreciation and increased material, labor and energy costs.

Operating expenses. Operating expenses were RMB91.4 million (US$14.1 million) for the second quarter of 2011, representing an increase of 35.9% from RMB67.2 million (US$9.9 million) for the same period in 2010.

  • Research and development ("R&D") costs. R&D costs for the second quarter of 2011 were RMB10.7 million (US$1.7 million), or 7.8% of net revenues, compared to RMB5.7 million (US$0.8 million), or 5.4% of net revenues, for the same period in 2010. The increase in R&D expenses is primarily attributable to clinical trial and testing expenses related to cancer therapeutics developed in collaboration with Ascentage Pharma and NuPIAO, our second generation version of EPIAO.
  • Sales, marketing and distribution expenses. Sales, marketing and distribution
    '/>"/>

  • SOURCE 3SBio Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

    Related medicine technology :

    1. 3SBio Inc. Schedules Unaudited Second Quarter 2011 Results
    2. 3SBio Inc. Announces SFDA Approval of High-Dose EPIAO
    3. 3SBio Announces Conversion of Isotechnika Debenture
    4. 3SBio Inc. Schedules Third Quarter 2010 Unaudited Financial Results
    5. 3SBio Announces Partial Conversion of Isotechnika Debenture
    6. 3SBio Announces Investor Conference Schedule
    7. 3SBio and Isotechnika Pharma Announce Strategic Partnership to Develop and Commercialize Voclosporin in China
    8. 3SBio Inc. Announces Results of Annual General Meeting
    9. NewCardio Announces Financial Results for Its 2011 Second Quarter
    10. Dehaier Medical Announces Record Second Quarter 2011 Financial Results
    11. Emdeon Announces Support for Electronic Prescribing of Controlled Substances Using the DEA-Allowed Quicker-to-Market Approach
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... 2015  MedScope ( www.medscope.org ), the leading provider of ... Connected World magazine Connected World Award for ... can be used anywhere, anytime. The nomination was made ... In nominating MedScope, Landon Garner , Director of ...
    (Date:1/23/2015)... all-time hits leader, is the new spokesperson for the topical ... announced. "Pete,s a Hall of Famer in our ... with Myoflex," said Ducere Pharma Chief Executive Officer Chris ... across all generations. The passion and intensity that Pete brought ...
    (Date:1/23/2015)... EAST SETAUKET, N.Y. , Jan. 23, 2015  Lixte Biotechnology ... sites where its Phase I trial of Lixte,s lead compound, ... 5 institutions. John S. Kovach , M.D., ... trial was planned to be completed at a single site. ...
    Breaking Medicine Technology:MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2Pete Rose bets on Myoflex to relieve aches and pains 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
    ... AUSTIN, Texas, Dec. 7, 2010 Luminex Corporation (Nasdaq: ... leading producer of transplant diagnostic products, have agreed to ... at developing platforms and technologies for human leukocyte antigen ... market. Begun in 2000, their dedicated collaboration has resulted ...
    ... PLYMOUTH MEETING, Pa., Dec. 7, 2010 Where do you ... ECRI Institute ( https://www.ecri.org ), an independent nonprofit that researches ... this question with the release of its 5th annual list ... Available now as a free download with registration, ...
    Cached Medicine Technology:Luminex and One Lambda Renew Long-Term Strategic Partnership 2Luminex and One Lambda Renew Long-Term Strategic Partnership 3ECRI Institute Releases 'Top 10 Health Technology Hazards for 2011' 2ECRI Institute Releases 'Top 10 Health Technology Hazards for 2011' 3
    (Date:1/22/2015)... Gabe’s Chemo Duck Program is pleased to announce the ... created for kids with cancer. The Chemo Duck App, available on ... with enjoyable games to help children of all ages living with ... to keep kids entertained, educated and at ease while waiting for ...
    (Date:1/22/2015)... Angelweddingdress is a famous wedding dress company ... to follow it on Facebook, Twitter, and Pinterest. The fans ... Angelweddingdress draws a lottery every week. , Moreover, the company ... 2015. Click Angelweddingdress homepage for more information. ...
    (Date:1/22/2015)... 2015 Juvent Sports ( http://www.juventsports.com ) ... PGA Merchandise Show to bestow a Juvent Sports Achievement ... golfer, Arlene McKitrick. The award commemorated and congratulated McKitrick ... win. She won her first amateur tournament in 1979 ...
    (Date:1/22/2015)... 22, 2015 For over 20 years, Dr. David ... and Vista area has treated just about every type of ... circumstances. And for those same twenty-plus years, the team at ... those injuries with the best possible doctor. With the ...
    (Date:1/22/2015)... Calif. (PRWEB) January 22, 2015 ... Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were ... their leadership in advancing biotechnology, biomedical science, medical ... and Olsen each received the “2014 Life Sciences ...
    Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3
    ... deaths from stroke in the US occur among postmenopausal women. ... women at risk be detected?// ,One way may ... sign of stroke risk is atheroma - fatty deposits in ... up through a dental x-ray. Researchers in California have assessed ...
    ... cancer should be screened periodically once in 5 years in ... blood test (FOBT) which looks for traces of blood shed ... the lower colon. According to researchers at the Finland Affairs ... has been decreased due to the routine screening.// ,They ...
    ... by mosquitoes.It is characterised by fever, chills,followed by excessive ... disease can lead to death even .This is a ... of this disease involves the control of breeding of ... spray the inside of their houses with insecticide to ...
    ... just provide a bridge to a transplant.Heart failure is characterised by ... the body. Till now, it has always been assumed that heart ... transplant.// ,The left ventricular assist device (LVAD) is a ... taking over some of its workload. It's used a bridge to ...
    ... animals, the nerve cells must communicate with the neurons by ... study, biologists from Utah showed how a single protein plays ... send these chemical signals. , The experimented animals were ... crippled the protein UNC-13. , " All our thoughts ...
    ... rates of heart disease and cancer, although few clinical studies have ... green tea in men with prostate cancer. They hope it will ... on the benefits of tea.// Generally tea drinkers are less ... still unknown. ,One likely reason is the high levels ...
    Cached Medicine News:
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: